SCHEMBL4895514

SCHEMBL4895514

CCc1ccc(S(=O)(=O)N(CC)Sc2ccc(C(F)(F)F)cc2)cc1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
ACLY P53396 1/20 0.38
SLC6A4 P31645 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
USP2 O75604 1/20 0.38
KDM1A O60341 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PTGDR2 Q9Y5Y4 2/20 0.37
PTPN1 P18031 1/20 0.36
HDAC8 Q9BY41 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906088 0.89 ALDH1A1 (0.45) LMNASLC6A4SMN1; SMN2KMT2APTGDR2
SCHEMBL4899866 0.89 LMNA (0.40) LMNAACLYSLC6A4SMN1; SMN2USP2
SCHEMBL4898117 0.86 ALDH1A1 (0.40) LMNAUSP2MEN1KMT2AHCRTR2
SCHEMBL4906037 0.86 ALDH1A1 (0.44) LMNASMN1; SMN2HDAC8HDAC3HDAC11
SCHEMBL4905476 0.85 ALDH1A1 (0.40) LMNAMEN1KMT2APTGDR2ALDH1A1
SCHEMBL4894384 0.84 HDAC8 (0.37) LMNASMN1; SMN2USP2KDM1APTGDR2
SCHEMBL4906844 0.84 POLB (0.41) LMNAPTGDR2
SCHEMBL4900993 0.83 LMNA (0.38) LMNAMEN1KMT2APSEN1PSEN2
SCHEMBL4906048 0.81 ALDH1A1 (0.45) LMNASMN1; SMN2KMT2APTGDR2HDAC8
SCHEMBL4905186 0.80 KMT2A (0.47) LMNASMN1; SMN2USP2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ACLY 563/4885SLC6A4 3494/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ACLY 563/4885SLC6A4 3494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.